{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:03:41Z","timestamp":1791529421130,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013709","name":"European Association of Cardiovascular Imaging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013709","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jchf.2022.08.022","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T13:59:58Z","timestamp":1670421598000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis"],"prefix":"10.1016","volume":"11","author":[{"given":"Georgios","family":"Georgiopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Figliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Pateras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0415-2912","authenticated-orcid":false,"given":"Dimitrios","family":"Bampatsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gherardo","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Chiribiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giorgio","family":"Masci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jchf.2022.08.022_bib1","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"39","key":"10.1016\/j.jchf.2022.08.022_bib2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Zamorano","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2022.08.022_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hjc.2021.06.005","article-title":"Validation of the new American College of Cardiology\/American Heart Association guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with hypertrophic cardiomyopathy","volume":"63","author":"Zegkos","year":"2022","journal-title":"Hellenic J Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2022.08.022_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/heartjnl-2019-315176","article-title":"Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy","volume":"106","author":"Ramchand","year":"2020","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.jchf.2022.08.022_bib5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2022.08.022_bib6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/eurheartj\/ehv529","article-title":"Myocardial strain imaging: how useful is it in clinical decision making?","author":"Smiseth","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jchf.2022.08.022_bib7","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.amjcard.2016.03.018","article-title":"Relation of\u00a0Doppler tissue imaging parameters with heart\u00a0failure progression in hypertrophic cardiomyopathy","volume":"117","author":"Kalra","year":"2016","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2022.08.022_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.jchf.2022.08.022_bib9","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of Observational Studies in Epidemiology: A proposal for reporting. Meta-analysis of observational studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2022.08.022_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.conctc.2017.11.012","article-title":"Interval estimation of the overall treatment effect in a meta-analysis of a few small studies with zero events","volume":"9","author":"Pateras","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"issue":"7","key":"10.1016\/j.jchf.2022.08.022_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/sim.7569","article-title":"Data-generating models of dichotomous outcomes: heterogeneity in simulation studies for a random-effects meta-analysis: data generating models of dichotomous outcomes","volume":"37","author":"Pateras","year":"2018","journal-title":"Stat Med"},{"key":"10.1016\/j.jchf.2022.08.022_bib12","unstructured":"R\u00fccker G, Krahn U, K\u00f6nig J, et al. Package \u2018netmeta.\u2019 Title: network meta-analysis using frequentist methods. Accessed April 11, 2022. https:\/\/cran.r-project.org\/web\/packages\/netmeta\/netmeta.pdf"},{"issue":"30","key":"10.1016\/j.jchf.2022.08.022_bib13","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1002\/sim.6001","article-title":"Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons","volume":"32","author":"K\u00f6nig","year":"2013","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jchf.2022.08.022_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.jchf.2022.08.022_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jchf.2022.08.022_bib16","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","article-title":"Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jchf.2022.08.022_bib17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.hrthm.2021.12.017","article-title":"Importance of newer cardiac magnetic resonance based risk markers for sudden death prevention in hypertrophic cardiomyopathy: an international multicenter study","volume":"19","author":"Rowin","year":"2022","journal-title":"Heart Rhythm"},{"issue":"38","key":"10.1016\/j.jchf.2022.08.022_bib18","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehab598","article-title":"Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy","volume":"42","author":"Nauffal","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jchf.2022.08.022_bib19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM","volume":"9","author":"Weng","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"8","key":"10.1016\/j.jchf.2022.08.022_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jchf.2022.08.022_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1136\/heartjnl-2013-305471","article-title":"Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy","volume":"100","author":"Ismail","year":"2014","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.jchf.2022.08.022_bib22","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1038\/s41598-017-06533-0","article-title":"Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy","volume":"7","author":"Doesch","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jchf.2022.08.022_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-021-00720-9","article-title":"Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation","volume":"23","author":"Raphael","year":"2021","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"7","key":"10.1016\/j.jchf.2022.08.022_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2022.08.022_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjcard.2022.02.006","article-title":"Echocardiographic and cardiac magnetic resonance imaging-derived strains in relation to late gadolinium enhancement in hypertrophic cardiomyopathy","volume":"171","author":"Klettas","year":"2022","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jchf.2022.08.022_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2022.08.022_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.jchf.2022.08.022_bib28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A\u00a0systematic review of medical costs associated with heart failure in the USA (2014\u20132020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jchf.2022.08.022_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2020.07.036","article-title":"Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy","volume":"318","author":"Ciabatti","year":"2020","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.jchf.2022.08.022_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.003951","article-title":"Recent advances in cardiovascular magnetic resonance","volume":"10","author":"Salerno","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.jchf.2022.08.022_bib31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2012.03.076","article-title":"Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"60","author":"Todiere","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2022.08.022_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ehjci\/jex134","article-title":"E\/e\u2019 ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction","volume":"19","author":"Lu","year":"2018","journal-title":"Eur Heart J Cardiovas Imaging"},{"issue":"10","key":"10.1016\/j.jchf.2022.08.022_bib33","article-title":"Incremental prognostic utility of left ventricular global longitudinal strain in hypertrophic obstructive cardiomyopathy patients and preserved left ventricular ejection fraction","volume":"6","author":"Tower-Rader","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jchf.2022.08.022_bib34","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000117098.75727.D8","article-title":"Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy","volume":"109","author":"Maron","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2022.08.022_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.618849","article-title":"The role of artificial intelligence in cardiovascular imaging: state of the art review","volume":"7","author":"Seetharam","year":"2020","journal-title":"Front Cardiovas Med"},{"issue":"10253","key":"10.1016\/j.jchf.2022.08.022_bib36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jchf.2022.08.022_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177922005704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177922005704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:01:31Z","timestamp":1761973291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177922005704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213177922005704"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2022.08.022","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2022.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}